Understanding, Avoiding, and Treating Potential Adverse Events Following the Use of Injectable Poly-L-Lactic Acid for Facial and Nonfacial Volumization

April 2014 | Volume 13 | Issue 4 | Supplement Individual Articles | 35 | Copyright © April 2014


Danny Vleggaar MD,a Rebecca Fitzgerald MD,b and Z. Paul Lorenc MD FACSc

aHead of Cosmetic Dermatology in Private Practice, Geneva, Switzerland bDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA cLorenc Aesthetic Plastic Surgery Center, New York, NY, USA

table 3
In the treatment of granulomas, surgical excision is not recommended due to their poorly defined borders and the potential for this approach to lead to fistulas, abscesses, or scars.9 Treatment is geared toward stopping both the increased secretion of interstitial substances and the invasion of cells.24 Approaches include the administration of steroids (intralesional, intramuscular, or systemic) with or without the coadministration of immune-modulating medications.9 Intralesionally injected 5-fluorouracil, alone or in combination with triamcinolone acetonide or betamethasone, are among other approaches demonstrated to be highly effective (Table 324; Figure 3). In addition, intense pulsed light can be a useful adjunct for the treatment of engorged capillaries.9 Recurrence following the successful treatment and resolution of granulomas is rare.9
table 4

SUMMARY

Injection-related AEs with the use of PLLA are generally transient and typically resolve spontaneously. Most patients simply need reassurance that the AEs will resolve on their own. To summarize simply, papules and nodules represent an overabundance of product with a predictable host reaction and granulomas represent a profound overabundance of host reaction to product. The occurrence of nodules, which are generally nonvisible and asymptomatic, has been minimized through improved methodology; if desired, they can be camouflaged via the injection of HA or surgically excised.